Journal Mobile Options
Table of Contents
Vol. 6, No. 3, 1999
Issue release date: May–June 1999
J Biomed Sci 1999;6:151–160
(DOI:10.1159/000025383)

Selenocysteine-Containing Proteins in Mammals

Gladyshev V.N. · Hatfield D.L.
aDepartment of Biochemistry, University of Nebraska, Lincoln, Nebr., and bSection on the Molecular Biology of Selenium, Basic Research Laboratory, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Since the recent discovery of selenocysteine as the 21st amino acid in protein, the field of selenium biology has rapidly expanded. Twelve mammalian selenoproteins have been characterized to date and each contains selenocysteine that is incorporated in response to specific UGA code words. These selenoproteins have different cellular functions, but in those selenoproteins for which the function is known, selenocysteine is located at the active center. The presence of selenocysteine at critical sites in naturally occurring selenoproteins provides an explanation for the important role of selenium in human health and development. This review describes known mammalian selenoproteins and discusses recent developments and future directions in the selenium field.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Arner ES, Bjornstedt M, Holmgren A. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J Biol Chem 270:3479–3482;1995.
  2. Aumann KD, Bedorf N, Brigelius-Flohe R, Schomburg D, Flohe L. Glutathione peroxidase revisited – Simulation of the catalytic cycle by computer-assisted molecular modelling. Biomed Environ Sci 10:136–155;1997.
  3. Baker A, Payne CM, Briehl MM, Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57:5162–5167;1997.
  4. Beck MA, Esworthy RS, Ho YS, Chu FF. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J 12:1143–1149;1998.
  5. Bedell MA, Jenkins NA, Copeland NG. Mouse models of human disease. Part I: Techniques and resources for genetic analysis in mice. Genes Dev 11:1–10;1997.
  6. Behne D, Hilmert H, Scheid S, Gessner H, Elger W. Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochim Biophys Acta 966:12–21;1988.
  7. Behne D, Kyriakopoulos A, Weiss-Nowak C, Kalckloesch M, Westphal C, Gessner H. Newly found selenium-containing proteins in the tissues of the rat. Biol Trace Elem Res 55:99–110;1996.
  8. Beilstein MA, Vendeland SC, Barofsky E, Jensen ON, Whanger PD. Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J Inorg Biochem 61:117–124;1996.
  9. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353:273–276;1991.
  10. Berry MJ, Banu L, Harney JW, Larsen PR. Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J 12:3315–3322;1993.
  11. Bjornstedt M, Xue J, Huang W, Akesson B, Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 269:29382–29384;1994.
  12. Bjornstedt M, Hamberg M, Kumar S, Xue J, Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 270:11761–11764;1995.
  13. Bjornstedt M, Kumar S, Holmgren A. Selenite and selenodiglutathione: Reactions with thioredoxin systems. Methods Enzymol 252:209–219;1995.
  14. Böck A. Incorporation of selenium into bacterial selenoprotein. In: (Burk RF, ed.) Selenium in Biology and Human Health. New York, Springer, 146–177;1994.
  15. Bosl MR, Takaku K, Oshima M, Nishimura S, Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc Natl Acad Sci USA 94:5531–5534;1997.
  16. Boyington JC, Gladyshev VN, Khangulov SV, Stadtman TC, Sun PD. Crystal structure of formate dehydrogenase H: Catalysis involving Mo, molybdopterin, selenocysteine, and an Fe4S4 cluster. Science 275:1305–1308;1997.
  17. Burk RF, Hill KE, Awad JA, Morrow JD, Kato T, Cockell KA, Lyons PR. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: Assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology 21:561–569;1995.
  18. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, Harrison PR. The structure of the mouse glutathione peroxidase gene: The selenocysteine in the active site is encoded by the ‘termination’ codon, TGA. EMBO J 5:1221–1227;1986.
  19. Ching WM. Occurrence of selenium-containing tRNAs in mouse leukemia cells. Proc Natl Acad Sci USA 81:3010–3013;1984.
  20. Ching WM, Tsai L, Wittwer AJ. Selenium-containing transfer RNAs. Curr Top Cell Regul 27:497–507;1985.
  21. Chittum HS, Himeno S, Hill KE, Burk RF. Multiple forms of selenoprotein P in rat plasma. Arch Biochem Biophys 325:124–128;1996.
  22. Chu FF, Esworthy RS, Ho YS, Bermeister M, Swiderek K, Elliott RW. Expression and chromosomal mapping of mouse Gpx2 gene encoding the gastrointestinal form of glutathione peroxidase, GPX-GI. Biomed Environ Sci 10:156–162;1997.
  23. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL, Park HK, Sanders BB, Smith CL, Taylor JR. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957–1963;1996.
  24. Croteau W, Davey JC, Galton VA, St Germain DL. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98:405–417;1996.
  25. Deiss LP, Kimchi A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science 252:117–120;1991.
  26. Dilworth GL. Properties of the selenium-containing moiety of nicotinic acid hydroxylase from Clostridium barkeri. Arch Biochem Biophys 219:30–38;1982.
  27. Dilworth GL. Occurrence of molybdenum in the nicotinic acid hydroxylase from Clostridium barkeri. Arch Biochem Biophys 221:565–569;1983.
  28. Engman L, Cotgreave I, Angulo M, Taylor CW, Paine-Murrieta GD, Powis G. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Anticancer Res 17:4599–4605;1997.
  29. Epp O, Ladenstein R, Wendel A. The refined structure of the selenoenzyme glutathione peroxidase at 0.2-nm resolution. Eur J Biochem 133:51–69;1983.
  30. Esworthy RS, Baker MA, Chu FF. Expression of selenium-dependent glutathione peroxidase in human breast tumor cell lines. Cancer Res 55:957–962;1995.
  31. Esworthy RS, Swiderek KM, Ho YS, Chu FF. Selenium-dependent glutathione peroxidase-GI is a major glutathione peroxidase activity in the mucosal epithelium of rodent intestine. Biochim Biophys Acta 1381:213–226;1998.
  32. Evan G, Littlewood T. A matter of life and cell death. Science 281:1317–1320;1998.
  33. Gallegos A, Gasdaska JR, Taylor CW, Paine-Murrieta GD, Goodman D, Gasdaska PY, Berggren M, Briehl MM, Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res 56:5765–5770;1996.
  34. Gallegos A, Berggren M, Gasdaska JR, Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57:4965–4970;1997.
  35. Gasdaska PY, Gasdaska JR, Cochran S, Powis G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett 373:5–9;1995.
  36. Gladyshev VN, Khangulov SV, Stadtman TC. Nicotinic acid hydroxylase from Clostridium barkeri: Electron paramagnetic resonance studies show that selenium is coordinated with molybdenum in the catalytically active selenium-dependent enzyme. Proc Natl Acad Sci USA 91:232–236;1994.
  37. Gladyshev VN, Khangulov SV, Stadtman TC. Properties of the selenium- and molybdenum-containing nicotinic acid hydroxylase from Clostridium barkeri. Biochemistry 35:212–223;1996.
  38. Gladyshev VN, Jeang KT, Stadtman TC. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci USA 93:6146–6151;1996.
  39. Gladyshev VN, Jeang KT, Wootton JC, Hatfield DL. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J Biol Chem 273:8910–8915;1998.
  40. Gladyshev VN, Diamond AM, Factor VM, Wootton JC, Moustafa M, Jeang KT, Berry MJ, Parodi A, Lee BJ, Hatfield DL. Association between a novel mammalian 15 kDa protein and cancer. FASEB J 12:A1431;1998.
  41. Gladyshev VN, Factor VM, Housseau F, Hatfield DL. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 251:488–493;1998.
  42. Gorlatov SN, Stadtman TC. Human thioredoxin reductase from HeLa cells: Selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc Natl Acad Sci USA 95:8520–8525;1998.
  43. Grate L. Potential SECIS elements in HIV–1 strain HXB2. J Acquir Immune Defic Syndr Hum Retrovirol 17:398–403;1998.
  44. Gromer S, Arscott LD, Williams CH Jr, Schirmer RH, Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 273:20096–20101;1998.
  45. Guimaraes MJ, Peterson D, Vicari A, Cocks BG, Copeland NG, Gilbert DJ, Jenkins NA, Ferrick DA, Kastelein RA, Bazan JF, Zlotnik A. Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: Is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci USA 93:15086–15091;1996.
  46. Hatfield DL, Diamond AM. UGA: A split personality in the universal genetic code. Trends Genet 9:69–70;1993.
  47. Hatfield DL, Choi IS, Ohama T, Jung JE, Diamond AM. Selenocysteine tRNA[Ser]Sec isoacceptors as central components is selenoprotein biosynthesis in eukaryotes. In: Burk RH, ed. Selenium in Biology and Human Health. New York, Springer, 26–44;1994.
  48. Hatfield DL, Gladyshev VN, Park J, Park SI, Chittum HS, Baek HJ, Carlson BA, Yang ES, Moustafa ME, Lee BJ. Biosynthesis of selenocysteine and its incorporation into protein as the 21st amino acid. Compr Nat Prod Chem 4:353–380;1999.
  49. Heider J, Böck A. Selenium metabolism in microorganisms. Adv Microb Physiol 35:71–109;1993.
  50. Hill KE, Lloyd RS, Burk RF. Conserved nucleotide sequences in the open reading frame and 3′ untranslated region of selenoprotein P mRNA. Proc Natl Acad Sci USA 90:537–541;1993.
  51. Hill KE, Burk RF. Selenoprotein P: Recent studies in rats and in humans. Biomed Environ Sci 10:198–208;1997.
  52. Hill KE, McCollum GW, Boeglin ME, Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 234:293–295;1997.
  53. Himeno S, Chittum HS, Burk RF. Isoforms of selenoprotein P in rat plasma. Evidence for a full-length form and another form that terminates at the second UGA in the open reading frame. J Biol Chem 271:15769–15775;1996.
  54. Ho YS, Magnenat JL, Bronson RT, Cao J, Gargano M, Sugawara M, Funk CD. Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity to hyperoxia. J Biol Chem 272:16644–16651;1997.
  55. Hofman ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, Jagus R, Gutierrez PL, Kalvakolanu DV. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 18:6493–6504;1998.
  56. Holmgren A. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J Biol Chem 252:4600–4606;1977.
  57. Khorana HG, Buchi H, Ghosh H, Gupta N, Jacob TM, Kossel H, Morgan R, Narang SA, Ohtsuka E, Wells RD. Polynucleotide synthesis and the genetic code. Cold Spring Harb Symp Quant Biol 31:39–49;1966.
  58. Kim IY, Guimaraes MJ, Zlotnik A, Bazan JF, Stadtman TC. Fetal mouse selenophosphate synthetase 2 (SPS2): Characterization of the cysteine mutant form overproduced in a baculovirus-insect cell system. Proc Natl Acad Sci USA 94:418–421;1997.
  59. Koishi R, Kawashima I, Yoshimura C, Sugawara M, Serizawa N. Cloning and characterization of a novel oxidoreductase KDRF from a human bone marrow-derived stromal cell line KM-102. J Biol Chem 272:2570–2577;1997.
  60. Kunkel MW, Kirkpatrick DL, Johnson JI, Powis G. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs. Anticancer Drug Des 12:659–670;1997.
  61. Liu SY, Stadtman TC. Heparin-binding properties of selenium-containing thioredoxin reductase from HeLa cells and human lung adenocarcinoma cells. Proc Natl Acad Sci USA 94:6138–6141;1997.
  62. Larsen PR. Update on the human iodothyronine selenodeiodinases, the enzymes regulating the activation and inactivation of thyroid hormone. Biochem Soc Trans 25:588–592;1997.
  63. Lee BJ, Park SI, Park JM, Chittum HS, Hatfield DL. Molecular biology of selenium and its role in human health. Mol Cells 6:509–520;1996.
  64. Leinfelder W, Zehelein E, Mandrand-Berthelot MA, Bock A. Gene for a novel tRNA species that accepts L-serine and cotranslationally inserts selenocysteine. Nature 331:723–725;1988.
  65. Low SC, Harney JW, Berry MJ. Cloning and functional characterization of human selenophosphate synthetase, an essential component of selenoprotein synthesis. J Biol Chem 270:21659–21664;1995.
  66. Low SC, Berry MJ. Knowing when not to stop: Selenocysteine incorporation in eukaryotes. Trends Biochem Sci 21:203–208;1996.
  67. Lundstrom J, Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem 265:9114–9120;1990.
  68. Lundstrom-Ljung J, Birnbach U, Rupp K, Soling HD, Holmgren A. Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: Comparison with protein disulfide isomerase. FEBS Lett 357:305–308;1995.
  69. Maiorino M, Wissing JB, Brigelius-Flohe R, Calabrese F, Roveri A, Steinert P, Ursini F, Flohe L. Testosterone mediates expression of the selenoprotein PHGPx by induction of spermatogenesis and not by direct transcriptional gene activation. FASEB J 12:1359–1370;1998.
  70. Marshall RE, Caskey CT, Nirenberg M. Fine structure of RNA codewords recognized by bacterial, amphibian, and mammalian transfer RNA. Science 155:820–826;1967.
  71. Mau BL, Powis G. Inhibition of thioredoxin reductase (E.C. 1.6.4.5.) by antitumor quinones. Free Radic Res Commun 8:365–372;1990.
  72. Mau BL, Powis G. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity. Biochem Pharmacol 43:1621–1627;1992.
  73. May JM, Mendiratta S, Hill KE, Burk RF. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem 272:22607–22610;1997.
  74. May JM, Cobb CE, Mendiratta S, Hill KE, Burk RF. Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase. J Biol Chem 273:23039–23045;1998.
  75. Nirenberg M, Caskey T, Marshall R, Brimacombe R, Kellogg D, Doctor B, Hatfield D, Levin J, Rottman F, Pestka S, Wilcox M, Anderson F. The RNA code and protein synthesis. Cold Spring Harb Symp Quant Biol 31:11–24;1966.
  76. Nordberg J, Zhong L, Holmgren A, Arner ES. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 273:10835–10842;1998.
  77. Porter A. Controlling your losses: Conditional gene silencing in mammals. Trends Genet 14:73–79;1998.
  78. Pushpa-Rekha TR, Burdsall AL, Oleksa LM, Chisolm GM, Driscoll DM. Rat phospholipid-hydroperoxide glutathione peroxidase. cDNA cloning and identification of multiple transcription and translation start sites. J Biol Chem 270:26993–26999;1995.
  79. Rajewsky K, Gu H, Kuhn R, Betz UA, Muller W, Roes J, Schwenk F. Conditional gene targeting. J Clin Invest 98:600–603;1996.
  80. Read R, Bellew T, Yang JG, Hill KE, Palmer IS, Burk RF. Selenium and amino acid composition of selenoprotein P, the major selenoprotein in rat serum. J Biol Chem 265:17899–17905;1990.
  81. Ren B, Huang W, Akesson B, Ladenstein R. The crystal structure of selenoglutathione peroxidase from human plasma at 2.9 Å resolution. J Mol Biol 268:869–885;1997.
  82. Rigobello MP, Callegaro MT, Barzon E, Benetti M, Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 24:370–376;1998.
  83. Rozell B, Hansson HA, Luthman M, Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38:79–86;1985.
  84. Rubartelli A, Bonifaci N, Sitia R. High rates of thioredoxin secretion correlate with growth arrest in hepatoma cells. Cancer Res 55:675–680;1995.
  85. Salvatore D, Bartha T, Harney JW, Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308–3315;1996.
  86. Stadtman TC. Selenocysteine. Annu Rev Biochem 65:83–100;1996.
  87. Sun QA, Wu YL, Zappacosta F, Jeang KT, Lee BJ, Hatfield DL, Gladyshev VN. Submitted.
  88. Sunde RA. Intracellular glutathione peroxidases – Structure, regulation, and function. In: (Burk RF, ed.) Selenium in Biology and Human Health. New York, Springer, 146–177;1994.
  89. Sunde RA, Thompson BM, Palm MD, Weiss SL, Thompson KM, Evenson JK. Selenium regulation of selenium-dependent glutathione peroxidases in animals and transfected CHO cells. Biomed Environ Sci 10:346–355;1997.
  90. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Akai K, Yokota T, Wakasugi H, et al. ATL-derived factor (ADF), an IL–2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL–2 receptor induction. EMBO J 8:757–764;1989.
  91. Tamura T, Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: Purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93:1006–1011;1996.
  92. Taylor EW, Ramanathan CS, Jalluri RK, Nadimpalli RG. A basis for new approaches to the chemotherapy of AIDS: Novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression. J Med Chem 37:2637–2654;1994.
  93. Ursini F, Maiorino M, Roveri A. Phospho- lipid hydroperoxide glutathione peroxidase (PHGPx): More than an antioxidant enzyme? Biomed Environ Sci 10:327–332;1997.
  94. Ursini F, Maiorino M, Brigelius-Flohe R, Aumann KD, Roveri A, Schomburg D, Flohe L. Diversity of glutathione peroxidases. Methods Enzymol 252:38–53;1995.
  95. U-Taniguchi Y, Furuke K, Masutani H, Nakamura H, Yodoi J. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: The possible therapeutic use of thioredoxin reductase inhibitors. Oncol Res 7:183–189;1995.
  96. Vendeland SC, Beilstein MA, Chen CL, Jensen ON, Barofsky E, Whanger PD. Purification and properties of selenoprotein W from rat muscle. J Biol Chem 268:17103–17107;1993.
  97. Vendeland SC, Beilstein MA, Yeh JY, Ream W, Whanger PD. Rat skeletal muscle selenoprotein W: cDNA clone and mRNA modulation by dietary selenium. Proc Natl Acad Sci USA 92:8749–8753;1995.
  98. Veres Z, Stadtman TC. A purified selenophosphate-dependent enzyme from Salmonella typhimurium catalyzes the replacement of sulfur in 2-thiouridine residues in tRNAs with selenium. Proc Natl Acad Sci USA 91:8092–8096;1994.
  99. Walczak R, Hubert N, Carbon P, Krol A. A novel RNA structural motif in the selenocysteine insertion element of eukaryotic selenoprotein mRNAs. RNA 2:367–379;1996.
  100. Waterston R, Sulston JE. The Human Genome Project: Reaching the finish line. Science 282:53–54;1998.
  101. Yeh JY, Vendeland SC, Gu Q, Butler JA, Ou BR, Whanger PD. Dietary selenium increases selenoprotein W levels in rat tissues. J Nutr 127:2165–2172;1997.
  102. Zhong L, Arner ES, Ljung J, Aslund F, Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 273:8581–8591;1998.
  103. Zinoni F, Birkmann A, Stadtman TC, Böck A. Nucleotide sequence and expression of the selenocysteine-containing polypeptide of formate dehydrogenase (formate-hydrogen-lyase-linked) from Escherichia coli. Proc Natl Acad Sci USA 83:4650–4654;1986.
  104. http://www.ncbi.nlm.nih.gov/ncicgap/expression_tech_info.html, 11/06/98.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50